Circulating antigens of dirofilaria immitis, monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens

• US 4,839,275 A
• Filed: 12/30/1985
• Issued: 06/13/1989
• Est. Priority Date: 12/01/1983
• Status: Expired due to Term

• Current Assignee: Barnes-Jewish Hospital (BJC Health System)
• Original Assignee: Jewish Hospital LLC (Community Health Systems Incorporated)
• Inventors: Weil, Gary J.
• Primary Examiner(s): PARR, MARGARET M
• Application Number:
  US06/814,684
• Time in Patent Office: 1,261 Days
• Field of Search: 530/387, 530/395, 424/85, 424/88, 424/117, 435/4, 435/7, 435/68, 435/70, 435/172.2, 435/188, 435/240, 435/241, 435/240.27, 935/89, 935/90, 935/92, 935/95, 935/103, 935/104, 935/106, 935/108, 935/110, 436/514-516, 436/518, 436/536-540, 436/543-548, 436/804, 436/806, 436/811
• US Class Current: 435/7.22
• CPC Class Codes: A61K 39/00 Medicinal preparations containing antigens or antibodies materials for immunoassay G01N33/53
• CPC Class Codes: C07K 16/20 from protozoa
• CPC Class Codes: Y10S 530/864 Monoclonal

Abstract

Novel hybrid cell lines are disclosed for providing monoclonal antibodies to circulating parasite antigens present in the blood of animals infected with the nematode parasite Dirofilaria immitis. Such circulating parasite antigens are also characterized and identified. Further disclosed are methods employed to produce and select such hybrid cell lines and diagnostically useful assay methods utilizing the monoclonal antibodies in the detection of such specific circulating parasite antigens in blood or bodily fluids.

Claims

1. Circulating parasite antigens of Dirofilaria immitis essentially purified and isolated from Dirofilaria immitis adult worms or infected dog serum treated with trichloroacetic acid and heat, said antigens characterized as follows:

(a) the antigens being present in Dirofilaria immitis worms and in the serum of animals infected with Dirofilaria immitis;

(b) being high molecular weight parasite antigens in infected dog sera as demonstrated by the immunoblot method with polyclonal and monoclonal antibodies;

(c) not being destroyed by trichloroacetic acid extraction or by perchloric acid extraction;

(d) not being destroyed by heat treatment at approximately 100°

C. for 30 minutes;

(e) having isoelectric points of under 4 as determined by a combination of ion exchange chromatography and rocket-line immunoelectrophoresis;

(f) migrating towards the anode at pH 8.6 in agarose gel (10 V/cm) with migration distances relative to albumin of 1.1 and about 1.0 as determined by crossed immunoelectrophoresis;

(g) forming lines of identity in rocket-line immunoelectrophoresis with soluble acid and heat-stable antigens extracted from adult D. immitis worms;

(h) being a subset of antigens produced in vitro by adult female D. immitis worms;

(i) having a phosphocholine determinant; and

(j) having determinants whose immunoreactivity is ablated by treatment thereof with sodium metaperiodate.

2. Mono-clonal antibody produced by hybridoma cell lines formed by fusion of cells from a mouse myeloma line and spleen cells from a mouse previously immunized with an antigenic extract prepared from the nematode parasite Dirofilaria immitis, which antibody binds to antigenic determinants of circulating parasite antigens of Dirofilaria immitis as defined in claim 1 and found in the serum of infected dogs, said antibody being further characterized by binding strongly to the uterine wall and to the eggs of Dirofilaria immitis female adult worms.

3. Monoclonal antibody of claim 2 which antibody binds to antigens determinants of circulating antigens of Dirofilaria immitis characterized as follows:

(a) the antigens being present in Dirofilaria immitis worms and in the serum of animals infected with Dirofilaria immitis;

(b) being high molecular weight parasite antigens in infected dog sera as demonstrated by the immunoblot method with polyclonal and monoclonal antibodies;

(c) not being destroyed by trichloroacetic acid extraction or by perchloric acid extraction;

(d) not being destroyed by heat treatment at approximately 100°

C. for 30 minutes;

(e) having isoelectric points of under 4 as determined by a combination of ion exchange chromatography and rocket-line immunoelectrophoresis;

(f) migrating towards the anode at pH 8.6 in agarose gel (10 V/cm) with migration distances relative to albumin of 1.1 and about 1.0 as determined by crossed immunoelectrophoresis;

(g) forming lines of identity in rocket-line immunoelectrophoresis with soluble acid and heat-stable antigens extracted from adult D. immitis worms;

(h) being a subset of antigens produced in vitro by adult female D. immitis worms;

(i) having a phosphocholine determinant; and

(j) having determinants whose immunoreactivity is ablated by treatment thereof with sodium metaperiodate.

4. A monoclonal antibody of claim 2 which is produced from a hybridoma formed by fusion of NS-1 myeloma cells and spleen cells from a BALB/C mouse previously immunized with an antigenic extract prepared from the nematode parasite Dirofilaria immitis.

5. A monoclonal antibody of claim 2 which antibody is specific for phosphoryl choline determinants.

6. A monoclonal antibody of claim 2 characterized in that determinants recognized by said antibody are sensitive to treatment with sodium metaperiodate.

13. An assay method for determining the presence of circulating parasite antigens of Dirofilaria immitis as defined in claim 1 in a sample of serum or plasma of a D. immitis-infected dog to which no parasite antigen or extract derived from D. immitis is added which comprises providing said sample, combining said sample with a monoclonal antibody which binds to antigenic determinants of said circulating parasite antigens of Dirofilaria immitis and determining whether said monoclonal antibody binds to said antigenic determinants of said circulating parasite antigens of Dirofilaria immitis whereby the presence or absence of said circulating parasite antigens is detected.

7. An assay method for determining the presence of circulating parasite antigens of Dirofilaria immitis in the serum of plasma of D. immitis-infected dogs which comprises combining a sample of serum or plasma from a dog infected with Dirofilaria immitis and to which no parasite antigen or extract derived from D. immitis is added with a first antibody bound to the surface of a solid support, adding thereto a conjugate composed of a second antibody and an enzyme and thereafter adding an enzyme substrate to indicate the presence of absence of said circulating parasite antigens in said sample.

8. An assay method as set forth in claim 7 wherein said first antibody is a polyclonal antibody.

9. An assay method as set forth in claim 8 wherein said second antibody is a monoclonal antibody which specifically binds to determinants present on said circulating parasite antigens.

10. An assay method as set forth in claim 7 wherein said first and second antibodies are monoclonal antibodies which specifically bind to determinants present on said circulating parasite antigens.

11. An assay method for determining the presence of circulating parasite antigens of Dirofilaria immitis in the serum of plasma of D. immitis-infected dogs which comprises combining a sample of serum or plasma from a dog infected with Dirofilaria immitis and to which no parasite antigen or extract derived from D. immitis is added with a first monoclonal antibody which specifically binds to determinants present on said circulating parasite antigens, and detecting the presence of said antigens by means of a label on said first antibody or by means of a label on a second antibody added to said first monoclonal antibody, said second antibody specifically binding to said circulating parasite antigens.

12. An assay method as set forth in claim 11 wherein said label is selected from the group consisting of radioactive labels, fluorescent compounds, enzymes, biotin and ferromagnetic labels.

14. An assay method for determining the presence of circulating parasite antigens of Dirofilaria immitis in a sample of serum or plasma of D. immitis-infected dogs to which no parasite antigen or extract derived from D. immitis is added which comprises the steps of:

(a) attaching a first antibody to a solid support, said first antibody being a polyclonal antibody which binds to antigenic determinants of said circulating parasite antigens of Dirofilaria immitis;

(b) combining said first antibody with said sample of serum or plasma from a dog infected with Dirofilaria immitis and a conjugate composed of an enzyme and a monoclonal antibody which binds to antigenic determinants of said circulating parasite antigens of Dirofilaria immitis whereby a polyclonal antibody-antigen-conjugated monoclonal antibody sandwich is formed; and

(c) thereafter adding an enzyme substrate to said sandwich to colorimetrically indicate the presence or absence of said circulating parasite antigens.